Get the Stockscreener App
54.42
7.44%
3.77
After Hours:
54.60
0.18
+0.33%
Grail Inc stock is traded at $54.42, with a volume of 588.26K.
It is up +7.44% in the last 24 hours and up +11.86% over the past month.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
See More
Previous Close:
$50.65
Open:
$50.99
24h Volume:
588.26K
Relative Volume:
0.48
Market Cap:
$2.23B
Revenue:
$147.17M
Net Income/Loss:
$-408.35M
P/E Ratio:
-4.8682
EPS:
-11.1787
Net Cash Flow:
$-299.92M
1W Performance:
+5.24%
1M Performance:
+11.86%
6M Performance:
-39.12%
1Y Performance:
+44.39%
1-Day Range:
$50.05
$54.98
1-Week Range:
$49.17
$54.98
52-Week Range:
$29.95
$118.84
Grail Inc Stock (GRAL) Company Profile
Name
Grail Inc
Sector
Industry
Phone
(833) 694-2553
Address
1525 O'BRIEN DRIVE, MENLO PARK
Compare GRAL vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GRAL
Grail Inc
|
54.42 | 2.23B | 147.17M | -408.35M | -299.92M | -11.18 |
TMO
Thermo Fisher Scientific Inc
|
469.71 | 174.55B | 45.20B | 6.88B | 6.75B | 18.19 |
DHR
Danaher Corp
|
177.25 | 125.45B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
565.93 | 44.95B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
115.55 | 32.65B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
309.87 | 30.42B | 3.17B | 642.63M | 516.49M | 10.77 |
Grail Inc Stock (GRAL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-26 | Initiated | Mizuho | Neutral |
| Mar-18-26 | Upgrade | TD Cowen | Hold → Buy |
| Feb-19-26 | Initiated | TD Cowen | Hold |
| Feb-17-26 | Initiated | Robert W. Baird | Outperform |
| Dec-02-25 | Resumed | Morgan Stanley | Equal-Weight |
| Nov-12-25 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-21-25 | Initiated | Canaccord Genuity | Buy |
| Nov-27-24 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Initiated | Wolfe Research | Peer Perform |
| Oct-17-24 | Initiated | Guggenheim | Neutral |
View All
Grail Inc Stock (GRAL) Latest News
GRAIL and athenahealth partner to simplify ordering of cancer detection test - MSN
Why GRAIL Inc Shares Are Surging Again Now - TipRanks
UBS AG (AMUB) sells $575K autocallable notes tied to GRAIL (GRAL) stock - Stock Titan
Grail, Epic plan Galleri test integration for 450 health systems - MSN
GRAL (GRAIL Inc.) posts narrower Q4 2025 loss and 17.2 percent revenue growth, shares dip 1.39 percent today.Guidance Update - Cổng thông tin điện tử tỉnh Tây Ninh
GRAIL (GRAL) Price Target Decreased by 10.52% to 85.07 - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating GRAIL, Inc. (GRAL) And Encourages Shareholders to Connect - The National Law Review
GRAIL to Announce First Quarter 2026 Financial Results - marketscreener.com
GRAIL schedules May 5 webcast after Q1 results release - Stock Titan
GRAIL, Inc. Experiences Revision in Stock Evaluation Amid Market Volatility - Markets Mojo
Key Study of Grail’s Cancer Detection Test Fails in Setback for Company - vocal.media
GRAIL to present NHS-Galleri, PATHFINDER 2 data at ASCO meeting - Investing.com Australia
GRAIL to present NHS-Galleri, PATHFINDER 2 data at ASCO meeting By Investing.com - Investing.com South Africa
GRAIL to Present New Data From NHS-Galleri and PATHFINDER 2 at 2026 ASCO Annual Meeting - ChartMill
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GRAIL, Inc. (GRAL) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
GRAIL partners with Epic to broaden Galleri test access across US - MSN
GRAIL, Inc. (GRAL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Archaeopteryx | The Holy Grail of Fossils at the Field Museum - Britannica
GRAL SEC FilingsGrail Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Why Is GRAL Stock Rising Today? - MSN
GRAIL (GRAL) director Steven Mizell takes $19.7K in deferred stock units - Stock Titan
GRAIL (GRAL) director receives 408 deferred stock units as fees - Stock Titan
GRAIL (GRAL) director takes $31.4K in stock units instead of cash fees - Stock Titan
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against GRAIL, Inc. (GRAL) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
GRAIL, Inc. (GRAL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GRAIL, Inc. (GRAL) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Levi & Korsinsky, LLP: Grail (GRAL) Guided to 2030 Cash Runway While Key Trial Risk Went Unaddressed - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating GRAIL, Inc. (GRAL) And Encourages Investors to Connect - ACCESS Newswire
GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES - PR Newswire
(GRAL) Volatility Zones as Tactical Triggers - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages GRAIL, Inc. (GRAL) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
2026-04-14 | Bronstein, Gewirtz & Grossman, LLC Encourages GRAIL, Inc. (GRAL) Stockholders to Inquire about Securities Investigation | NDAQ:GRAL | Press Release - Stockhouse
Mizuho Securities Maintains Grail(GRAL.US) With Hold Rating, Maintains Target Price $58 - Moomoo
GRAIL rated new Neural at Mizuho and Piper after study setback - MSN
Bronstein, Gewirtz & Grossman, LLC Is Investigating GRAIL, Inc. (GRAL) And Encourages Stockholders to Connect - ACCESS Newswire
A Look At GRAIL (GRAL) Valuation After New Galleri Integrations With Epic Junction And Superpower - Yahoo Finance
GRAIL2026 Funding Rounds & List of Investors - Tracxn
Mizuho initiates coverage of GRAIL (GRAL) with neutral recommendation - MSN
GRAIL, Inc. $GRAL Shares Sold by Carnegie Investment Counsel - MarketBeat
GRAIL (NASDAQ:GRAL) Stock Rating Lowered by Wall Street Zen - MarketBeat
Piper Sandler initiates coverage of GRAIL (GRAL) with neutral recommendation - MSN
GRAIL, Inc. (GRAL) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
GRAIL (NASDAQ:GRAL) Now Covered by Analysts at Piper Sandler - MarketBeat
Mizuho Initiates GRAIL at Neutral With $58 Price Target - marketscreener.com
This WhiteFiber Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga
Mizuho initiates Grail stock coverage with neutral rating on MCED outlook - Investing.com
Mizuho initiates Grail stock coverage with neutral rating on MCED outlook By Investing.com - Investing.com South Africa
Piper Sandler initiates Grail stock coverage with neutral rating By Investing.com - Investing.com South Africa
Piper Sandler initiates Grail stock coverage with neutral rating - Investing.com UK
Junction Collaborates with GRAIL to Power Scalable Access to the Galleri® Multi-Cancer Early Detection Test - BioSpace
Grail Inc Stock (GRAL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.42%
1.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):